Summit Therapeutics, Inc. (SMMT)
17.02
-1.60
(-8.62%)
USD |
NASDAQ |
Dec 09, 16:00
17.38
+0.36
(+2.12%)
After-Hours: 07:46
Summit Therapeutics Shareholders Equity (Quarterly): 192.26M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 51.85B |
| CVS Health Corp. | 72.93B |
| UnitedHealth Group, Inc. | 95.79B |
| Iovance Biotherapeutics, Inc. | 702.29M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 261.73M |
| Total Liabilities (Quarterly) | 69.47M |
| Debt to Equity Ratio | 0.0282 |
| Current Ratio | 3.796 |
| Net Debt Paydown Yield | 0.13% |